Dornase Alfa vs Pembrolizumab

## Dornase Alfa vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Dornase Alfa** and **Pembrolizumab**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Dornase Alfa — N/A; Pembrolizumab — 26 days.

## Chemical Properties

**Type**: Dornase Alfa — Enzyme; Pembrolizumab — Antibody.